NO952175L - Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II - Google Patents
Nukleotidsekvens som koder for karbamoylfosfatsyntetitase IIInfo
- Publication number
- NO952175L NO952175L NO952175A NO952175A NO952175L NO 952175 L NO952175 L NO 952175L NO 952175 A NO952175 A NO 952175A NO 952175 A NO952175 A NO 952175A NO 952175 L NO952175 L NO 952175L
- Authority
- NO
- Norway
- Prior art keywords
- carbamoyl phosphate
- sequence encoding
- nucleotide sequence
- synthetitase
- phosphate synthetase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/93—Ligases (6)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y603/00—Ligases forming carbon-nitrogen bonds (6.3)
- C12Y603/05—Carbon-nitrogen ligases with glutamine as amido-N-donor (6.3.5)
- C12Y603/05005—Carbamoyl-phosphate synthase (glutamine-hydrolysing) (6.3.5.5)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
En nukleotidsekvens kodende for karbamoylfosfatsyntetase II til Plasmodium falciparum er beskrevet. Karbamoylfosfatsymetase II katalyserer det første rate- begrensede trinnet i de novo pyrimidin biosyntesereaksjonsveien. P.falciparum er avhengig av pyrimidin syntese de novo på grunn av dets manglende evne til overføring av pyrimidiner. Modne humane røde blodceller er ikke et anerkjent krav på et pyridimidinnukleotid. Dette enzymet representerer følgelig et primært kjemoterapeutisk lokus. Anvendelse av sekvensen kodende for karbamoylfosfat- syntetase II i rekombinant produksjon av karbamoylfosfatsyntetase II og anti- sensmolekyler, ribozymer og andre geninaktiveringsmidler konstruert fra denne sekvensen, er også beskrevet.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AUPL620692 | 1992-12-03 | ||
AUPL638092 | 1992-12-16 | ||
PCT/AU1993/000617 WO1994012643A1 (en) | 1992-12-03 | 1993-12-02 | Nucleotide sequence encoding carbamoyl phosphate synthetase ii |
Publications (2)
Publication Number | Publication Date |
---|---|
NO952175D0 NO952175D0 (no) | 1995-06-01 |
NO952175L true NO952175L (no) | 1995-06-01 |
Family
ID=25644386
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO952175A NO952175L (no) | 1992-12-03 | 1995-06-01 | Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II |
Country Status (17)
Country | Link |
---|---|
US (1) | US5849573A (no) |
EP (1) | EP0675958A4 (no) |
JP (1) | JPH08503607A (no) |
KR (1) | KR950704495A (no) |
CN (1) | CN1041535C (no) |
AP (1) | AP429A (no) |
BR (1) | BR9307584A (no) |
CA (1) | CA2150572A1 (no) |
FI (1) | FI952697A (no) |
HU (2) | HUT71930A (no) |
IL (1) | IL107845A0 (no) |
MX (1) | MX9307662A (no) |
MY (1) | MY109022A (no) |
NO (1) | NO952175L (no) |
OA (1) | OA10163A (no) |
PL (1) | PL309261A1 (no) |
WO (1) | WO1994012643A1 (no) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6468765B1 (en) * | 1995-04-21 | 2002-10-22 | Human Genome Sciences, Inc. | Selected Haemophilus influenzae Rd polynucleotides and polypeptides |
US6610478B1 (en) | 1996-08-16 | 2003-08-26 | Yale University | Phenotypic conversion of cells mediated by external guide sequences |
WO1998006440A2 (en) * | 1996-08-16 | 1998-02-19 | Innovir Laboratories, Inc. | Phenotypic conversion of cells mediated by external guide sequences |
WO1999063067A1 (en) * | 1998-06-01 | 1999-12-09 | Incyte Pharmaceuticals, Inc. | Carbamoyl phosphate synthase homolog |
CN100510079C (zh) * | 2001-04-04 | 2009-07-08 | 中国医学科学院基础医学研究所 | 恶性疟原虫蛋白基因 |
CN100510080C (zh) * | 2001-04-04 | 2009-07-08 | 中国医学科学院基础医学研究所 | 恶性疟原虫新的抗原候选基因PfMAg |
CN1316015C (zh) * | 2001-08-03 | 2007-05-16 | 味之素株式会社 | 新突变型氨甲酰磷酸合成酶以及生产由氨甲酰磷酸衍生的化合物的方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5585479A (en) * | 1992-07-24 | 1996-12-17 | The United States Of America As Represented By The Secretary Of The Navy | Antisense oligonucleotides directed against human ELAM-I RNA |
-
1993
- 1993-12-01 AP APAP/P/1994/000607A patent/AP429A/en active
- 1993-12-02 WO PCT/AU1993/000617 patent/WO1994012643A1/en not_active Application Discontinuation
- 1993-12-02 KR KR1019950702245A patent/KR950704495A/ko not_active Application Discontinuation
- 1993-12-02 BR BR9307584-7A patent/BR9307584A/pt not_active Application Discontinuation
- 1993-12-02 PL PL93309261A patent/PL309261A1/xx unknown
- 1993-12-02 US US08/446,855 patent/US5849573A/en not_active Expired - Fee Related
- 1993-12-02 CA CA002150572A patent/CA2150572A1/en not_active Abandoned
- 1993-12-02 EP EP94900652A patent/EP0675958A4/en not_active Ceased
- 1993-12-02 HU HU9501583A patent/HUT71930A/hu unknown
- 1993-12-02 JP JP6512592A patent/JPH08503607A/ja not_active Ceased
- 1993-12-02 IL IL10784593A patent/IL107845A0/xx unknown
- 1993-12-02 MY MYPI93002571A patent/MY109022A/en unknown
- 1993-12-03 CN CN93121697A patent/CN1041535C/zh not_active Expired - Fee Related
- 1993-12-03 MX MX9307662A patent/MX9307662A/es unknown
-
1995
- 1995-06-01 NO NO952175A patent/NO952175L/no unknown
- 1995-06-02 OA OA60671A patent/OA10163A/en unknown
- 1995-06-02 FI FI952697A patent/FI952697A/fi not_active Application Discontinuation
- 1995-06-20 HU HU95P/P00284P patent/HU211526A9/hu unknown
Also Published As
Publication number | Publication date |
---|---|
AP9400607A0 (en) | 1994-01-31 |
WO1994012643A1 (en) | 1994-06-09 |
IL107845A0 (en) | 1994-04-12 |
BR9307584A (pt) | 1999-08-31 |
NO952175D0 (no) | 1995-06-01 |
MX9307662A (es) | 1994-06-30 |
CN1041535C (zh) | 1999-01-06 |
FI952697A (fi) | 1995-07-14 |
HU211526A9 (en) | 1995-11-28 |
PL309261A1 (en) | 1995-10-02 |
EP0675958A4 (en) | 1997-10-22 |
CA2150572A1 (en) | 1994-06-09 |
HUT71930A (en) | 1996-02-28 |
FI952697A0 (fi) | 1995-06-02 |
JPH08503607A (ja) | 1996-04-23 |
AP429A (en) | 1995-11-09 |
KR950704495A (ko) | 1995-11-20 |
MY109022A (en) | 1996-11-30 |
HU9501583D0 (en) | 1995-08-28 |
CN1090327A (zh) | 1994-08-03 |
EP0675958A1 (en) | 1995-10-11 |
US5849573A (en) | 1998-12-15 |
OA10163A (en) | 1996-12-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1047129A1 (en) | Sequence-specific dna recombination in eukaryotic cells | |
Switchenko et al. | Intermediates in the enzymic synthesis of tetrahydrobiopterin in Drosophilamelanogaster | |
NO952175L (no) | Nukleotidsekvens som koder for karbamoylfosfatsyntetitase II | |
Wang et al. | Salvage of pyrimidine nucleosides by Trichomonas vaginalis | |
Senesi et al. | A specific adenosine phosphorylase, distinct from purine nucleoside phosphorylase | |
Miovic et al. | Effect of trimethoprim on macromolecular synthesis in Escherichia coli | |
EP0293193A3 (en) | Gene transfer for drug resistance | |
Hartman et al. | PROTEINASE BIOSYNTHESIS BY STREPTOCOCCUS LIQUEFACIENS: II. PURINE, PYRIMIDINE, AND VITAMIN REQUIREMENTS | |
NO20016270L (no) | Vektorer, celler og fremgangsmåter for fremstilling av pyrimidindeoksyribonukleosider | |
Schmidt | Metabolism of nucleic acids | |
HUT71096A (en) | Process for the preparation of 2-amino-4,6-dichloro-pyrimidine | |
MX9700951A (es) | Promotor de fblato. | |
ES2016227A4 (es) | 54- procedimiento para la elaboracion de aminoacidos l-alfa. | |
WO2001025415A3 (de) | Gentransfer in humane lymphocyten mittels retroviraler scfv-zelltargeting vektoren | |
Senesi et al. | Adenosine phosphorylase from vegetative forms and free spores of Bacillus subtilis: properties and possible physiological role | |
Fox et al. | AICAR is not an endogenous mutagen in Escherichia coli | |
WO1999063071A3 (de) | Verfahren zur auslösung von apoptose in zellen | |
EP1806405A3 (en) | Vectors, cells and processes for pyrimidine deoxyribonucleosides production | |
Hurt | PROPERTIES OF A SUPPRESSED THYMIDYLATE SYNTHETASE MUTANT OF BACILLUS SUBTILIS. | |
HUP0202722A2 (hu) | Szekvencia-specifikus DNS-rekombináció eukarióta sejtekben | |
Hirayama et al. | Regulation of tetrahydrobiopterin biosynthesis in cultured hypothalamic and mesencephalic neurons by cyclic AMP dependent GTP cyclohydrolase I gene expression | |
Nishida et al. | Properties and Activities of Phosphoribomutase in Human Leukemic Cells | |
Mukai et al. | Streptomyces nucleotide 3′-pyrophosphokinase. Synthesis of deoxynucleotide-3′-pyrophosphates and 3′-pyrophosphoryl→ 3′-OH transfer activity | |
Heyworth et al. | Heterogeneity of lysosomal enzymes in cultured normal and sialidosis type II human fibroblasts and the effect of ammonium chloride on this heterogeneity | |
Harada et al. | Mycophenolic acid simultaneously reduces intracellular GTP and tetrahydrobiopterin levels in neuro-2A cells |